Description

Selepressin Acetate is a synthetic selective agonist of the vasopressin V1A receptor, known for its potent vasoconstrictive effects. It mimics the natural hormone vasopressin and is mainly researched for its role in treating septic shock by modulating vascular tone and improving hemodynamic stability.

With a purity of 98.77% and manufactured under GMP standards, Selepressin Acetate offers high-quality consistency required for in vitro and in vivo experimental models. Researchers use it to explore therapeutic approaches for cardiovascular dysfunction and septic shock management, focusing on its selective receptor activity to avoid side effects linked with other vasopressin receptors.

Selepressin Acetate is suitable for wholesale and retail distribution, intended strictly for laboratory research purposes.

Product Specifications

Mechanism of Action & Research Applications

Selepressin Acetate acts as a selective agonist of the vasopressin V1A receptor, promoting vasoconstriction and regulation of vascular tone. It is studied extensively for its potential in managing septic shock by stabilizing blood pressure and reducing the requirement for catecholamine vasopressors. Its selective receptor profile minimizes side effects associated with non-selective vasopressin receptor activation.

Research applications include cardiovascular pharmacology, septic shock pathophysiology, and therapeutic drug development targeting vasopressin receptors.

Side Effects (For Reference Only)

Since Selepressin Acetate is intended solely for experimental use, clinical side effects have not been fully characterized. Researchers should follow proper laboratory safety protocols to mitigate exposure risks.

Disclaimer

This product is exclusively for laboratory research purposes. It is not approved for diagnostic, therapeutic, or clinical use in humans or animals. All users must adhere to institutional safety and regulatory guidelines.